Mesenchymal Stem Cell Secretion of SDF-1α Modulates Endothelial Function in Dilated Cardiomyopathy
BackgroundEndothelial dysfunction contributes to the pathophysiology of dilated cardiomyopathy (DCM). Allogeneic but not autologous mesenchymal stem cells (MSCs) improve endothelial function in DCM patients. We hypothesized that these effects are modulated by release of stromal derived factor-1α (SD...
Main Authors: | Courtney Premer, Amarylis Wanschel, Valeria Porras, Wayne Balkan, Tatiana Legendre-Hyldig, Russell G. Saltzman, Chunming Dong, Ivonne Hernandez Schulman, Joshua M. Hare |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-09-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphys.2019.01182/full |
Similar Items
-
Mesenchymal Stem Cell Therapy for Aging Frailty
by: Ivonne Hernandez Schulman, et al.
Published: (2018-11-01) -
Rethinking Endothelial Dysfunction as a Crucial Target in Fighting Heart Failure
by: Courtney Premer, PhD, et al.
Published: (2019-03-01) -
Chemically Modified SDF-1α mRNA Promotes Random Flap Survival by Activating the SDF-1α/CXCR4 Axis in Rats
by: Zucheng Luo, et al.
Published: (2021-02-01) -
Renovascular and renoprotective properties of telmisartan: clinical utility
by: Marco Ladino, et al.
Published: (2010-03-01) -
Association of SDF-1 with Metastasis in Breast Cancer Patient at Sanglah Hospital, Bali
by: Kristanto Yuli Yarso, et al.
Published: (2016-10-01)